What Side Effects Are Common With GLP-1 Diabetes and Weight-Loss Injections?
GLP-1 injection side effects are mostly digestive, including nausea, vomiting, diarrhea, constipation, belching and abdominal discomfort. They often appear when treatment starts or the dose goes up, and many people find they ease over time.
Written By: DocAi Health Editorial Team
Last Updated: 2026-09-21
GLP-1 injection side effects are mostly digestive, including nausea, vomiting, diarrhea, constipation, belching and abdominal discomfort. They often appear when treatment starts or the dose goes up, and many people find they ease over time. Less common problems, such as pancreatitis, gallbladder disease, dehydration and low blood sugar when combined with some other diabetes medicines, need prompt attention. This article covers what to expect, what may help, and which symptoms need urgent care.
Common side effects of GLP-1 injections
GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda) and dulaglutide (Trulicity). Tirzepatide (Mounjaro, Zepbound) activates both GIP and GLP-1 receptors, and its labeled side effects are similar. These medicines are used for type 2 diabetes and, in some brands, for weight management. MedlinePlus lists diabetes medicines in several classes, and injectable GLP-1 drugs are one of them.
The side effects you are most likely to notice are digestive:
- Nausea, sometimes with a feeling of fullness after very small meals.
- Vomiting, which can be occasional or, in some people, frequent.
- Diarrhea or loose, urgent stools.
- Constipation, which may alternate with diarrhea.
- Belching, bloating, gas and heartburn.
- Abdominal discomfort that is mild and comes and goes.
Other effects that people report include reduced appetite, tiredness, headache, dizziness, and redness, itching or a small lump where the injection was given. Some people notice hair thinning during weight loss. The cause of that is not fully understood, and several factors, including rapid weight loss and lower calorie intake, may contribute.
Why these medicines upset the stomach
GLP-1 medicines mimic a gut hormone that helps release insulin after meals, lowers glucagon, and signals fullness to the brain. They also slow how quickly the stomach empties. That slower emptying is one reason you feel full sooner, and it is also a likely contributor to nausea, bloating and reflux. The brain's appetite and nausea centers may also play a part. Several mechanisms probably contribute, and the exact balance differs from person to person.
Because the stomach and bowel move more slowly, tell your clinician before starting if you have severe gastroparesis (a stomach that already empties poorly) or a history of bowel obstruction, so they can weigh the risks for you.
When side effects usually show up and how long they last
Digestive symptoms often show up when you first start the medicine and again after a dose increase. For this reason, these drugs are typically started at a low dose and raised in steps according to the product's prescribing information. Many people find symptoms settle as the body adjusts, but that is not true for everyone. Some people have persistent symptoms that lead them and their prescriber to slow the schedule, hold at a lower dose or choose a different medicine.
Do not change the timing or dose on your own. If the symptoms are hard to live with, tell your prescriber so they can decide whether to adjust the plan.
Missed-dose windows differ by product (once-weekly and daily pens have different instructions), so check the prescribing information that came with your pen or ask your pharmacist before taking a late dose, and do not double up on your own. After a long gap between doses, ask your prescriber whether you should restart at a lower dose, because digestive side effects can return when treatment resumes.
Practical ways people ease nausea, constipation and reflux
These steps are general comfort measures. Your clinician or pharmacist can tailor them to you, especially if you have kidney disease, heart failure or take other medicines.
- Eat smaller portions more slowly. Stopping when you feel comfortably full may reduce nausea and vomiting.
- Go easy on greasy, fried, very sweet or large meals. These can sit longer in a slowed stomach and may worsen symptoms.
- Sip fluids through the day. This helps protect against dehydration, which can make dizziness and constipation worse.
- Add fiber gradually from vegetables, beans, fruit and whole grains if constipation is the issue, and discuss laxatives with a pharmacist or clinician before starting one.
- Avoid lying down right after eating if you have reflux or heartburn.
- Ask about anti-nausea or antidiarrheal options. Your clinician can say which are appropriate for your other conditions and medicines.
Quick guide to symptoms and next steps
| Symptom | What may help | When to get care |
|---|---|---|
| Mild nausea | Smaller meals, slower eating, avoiding greasy food | If it persists or you cannot eat or drink enough |
| Vomiting or diarrhea | Small sips of fluid, rest | Same day if you cannot keep fluids down or urinate very little; emergency care if you faint, become confused or cannot stand |
| Constipation | Fluids, gradual fiber, activity | Emergency care if it comes with severe belly pain or swelling, repeated vomiting and no passing of stool or gas; same day if it is severe |
| Injection site redness or lump | Rotating sites as your label instructs | If it spreads, is very painful or looks infected |
Dehydration and kidney strain
Vomiting and diarrhea can cause fluid loss. The prescribing information for these medicines lists acute kidney injury as a reported event, usually in the setting of dehydration from severe or persistent digestive symptoms, and the risk may be higher in people who already have kidney disease or take certain blood pressure or water-removing medicines. Signs of dehydration include dark urine, urinating much less than usual, a dry mouth, lightheadedness when standing and unusual weakness. If you cannot keep fluids down, contact your clinician the same day, because you may need testing or a plan for your other medicines. Fainting, confusion or being unable to stand after repeated vomiting or diarrhea needs emergency care.
Pancreatitis, bowel obstruction and gallbladder problems
Inflammation of the pancreas (pancreatitis) has been reported with GLP-1 medicines. The typical picture is severe, persistent pain in the upper abdomen that may spread to the back, often with vomiting. It is different from the mild cramping that comes and goes. If you have severe, persistent abdominal pain, get emergency medical care and tell the team that you use a GLP-1 medicine. The prescribing information says the medicine should be stopped if pancreatitis is suspected, and a clinician decides about any restart, so let the emergency team and your prescriber make that decision with you.
Intestinal blockage (ileus or bowel obstruction) has also been reported after these medicines reached the market. Severe constipation with a swollen belly, repeated vomiting and no passing of stool or gas needs emergency evaluation.
Gallbladder disease, including gallstones, has also been reported, and rapid weight loss can contribute by itself. Pain in the upper right abdomen, especially after meals, can be an early sign. With fever, shaking chills, yellowing of the skin or eyes, or pale stools, it needs urgent medical evaluation, in the emergency room if you cannot be seen right away. Clinicians combine your history, examination and testing to tell these conditions apart, and abdominal pain should not be assumed to be an ordinary side effect.
Low blood sugar: when the combination matters
GLP-1 medicines on their own carry a lower risk of low blood sugar because they work in a glucose-dependent way. The risk rises when they are added to insulin or to sulfonylurea pills such as glipizide or glimepiride. Your prescriber may adjust those other medicines, so ask them rather than changing anything yourself. Eating much less can add to the risk. MedlinePlus describes hypoglycemia symptoms such as shakiness, sweating, fast heartbeat, hunger, confusion and irritability.
If you suspect a low, treat it right away with fast-acting carbohydrate such as juice or glucose tablets. The MedlinePlus hypoglycemia page describes about 15 grams, followed by rechecking your blood sugar. Call 911 for fainting, a seizure, an inability to swallow safely, or confusion that does not improve after fast-acting sugar.
Keep following the blood sugar monitoring plan your clinician gave you, and ask them whether it should change while you are eating less. Eating less can change your readings, and your care team relies on that information.
Boxed warning and other label cautions
According to their prescribing information, semaglutide, liraglutide, dulaglutide and tirzepatide products carry a boxed warning about thyroid C-cell tumors seen in rodents. It is not known whether these medicines cause such tumors in people. They are not recommended for anyone with a personal or family history of medullary thyroid carcinoma or with multiple endocrine neoplasia syndrome type 2. Tell your clinician about this history before starting. A new lump or swelling in the neck, hoarseness, or trouble swallowing or breathing should be evaluated promptly. These conditions are much less common than everyday digestive upset, and a single symptom does not establish a thyroid tumor.
Other cautions on the labels, which your prescriber or pharmacist can explain for your specific product, include:
- Allergic reactions. Swelling of the face, lips or throat, a widespread rash or trouble breathing is an emergency.
- Diabetic eye disease. In people with existing diabetic retinopathy, changes in vision have been reported with some GLP-1 medicines. Tell your eye clinician you are taking one. Any change in vision needs same-day evaluation, and sudden vision loss needs emergency care.
- Surgery and sedation. Slowed stomach emptying may raise the risk that food stays in the stomach during anesthesia. Tell the surgical or procedure team that you use a GLP-1 medicine so they can decide what instructions to give.
- Pregnancy and breastfeeding. Weight-management brands such as Wegovy and Zepbound are not recommended during pregnancy, and their labels advise stopping before a planned pregnancy (semaglutide labeling advises at least 2 months beforehand). Tell your prescriber if you are planning a pregnancy or become pregnant, so they can decide on a plan for your weight and diabetes care. Do not stop on your own without that plan.
- Birth control. Tirzepatide (Mounjaro, Zepbound) can reduce how well oral contraceptive pills work. The Mounjaro and Zepbound prescribing information advises a non-oral method or a backup method for 4 weeks after starting and after each dose increase; labeling can be updated, so confirm with your pharmacist. Ask your prescriber or pharmacist what fits your situation.
- Older adults and other medicines. Dehydration and falls from dizziness deserve extra attention, so share your full medicine list with the prescriber.
Weight loss, muscle and nutrition
Weight lost with these medicines includes some lean mass as well as fat, and eating very little can leave you short on protein, vitamins and fluid. A registered dietitian can help you plan balanced meals when appetite is low. Hair thinning, fatigue, and feeling cold can accompany rapid weight loss and low intake. Unplanned weight loss in someone who is not taking a medicine for it has different causes, which are covered in other articles on this site.
Questions to bring to your prescriber
- Which side effects should I expect with my product and dose?
- Should my insulin or sulfonylurea dose change, and who decides?
- How should I handle a missed dose or a long gap between doses?
- What should I do on days when I am vomiting or cannot drink?
- Do my other conditions, such as kidney disease, gastroparesis, bowel obstruction, gallstones, pancreatitis history or eye disease, change the risk?
For background on diabetes itself, MedlinePlus has overviews of type 2 diabetes and diabetes in general.
When to Seek Medical Care
When to Seek Urgent or Emergency Care
Most GLP-1 side effects are uncomfortable but manageable, yet a few reactions can become dangerous quickly. Use the first list for emergencies and the second for same-day or next-available care. This guidance is in addition to, not a replacement for, the general disclaimer above.
Emergency, call 911 or go to the emergency room immediately if:
- Swelling of the face, lips, tongue or throat, wheezing, or trouble breathing after an injection, which can be a severe allergic reaction.
- Severe, persistent abdominal pain that may spread to the back, with or without vomiting, or belly swelling with repeated vomiting and no passing of stool or gas, which can signal pancreatitis or a bowel obstruction; tell the emergency team you use a GLP-1 medicine, because the label says it should be stopped if pancreatitis is suspected and a clinician decides about any restart.
- Low blood sugar with fainting, a seizure, being unable to swallow safely, or confusion that does not improve after fast-acting sugar, particularly if you also use insulin or a sulfonylurea.
- Fainting, confusion or being unable to stand after repeated vomiting or diarrhea, which can signal serious dehydration and needs emergency care.
- Severe right upper abdominal pain with fever, shaking chills, or yellowing of the skin or eyes, which can be a sign of a gallbladder or bile duct problem and needs urgent evaluation in the emergency room if you cannot be seen right away.
- Sudden loss of vision, or stroke signs such as face drooping, arm weakness or trouble speaking, which need emergency care right away.
See a doctor soon (same-day or next available appointment) if:
- Vomiting or diarrhea that keeps you from holding down fluids, with dark urine, very little urine, or lightheadedness when you stand.
- Upper abdominal pain after meals, especially on the right side, that keeps returning or lasts longer each time.
- A new lump or swelling in the neck, hoarseness that does not clear, or trouble swallowing, so a clinician can evaluate it.
- Any change in vision, particularly if you have diabetic eye disease, needs same-day evaluation by your eye clinician; sudden vision loss is an emergency.
- Shakiness or sweating that clears fully with food or juice should be reported to your prescriber the same day, especially if you also use insulin or a sulfonylurea; confusion that does not clear fully with sugar is an emergency.
- Planned surgery, a procedure with sedation, pregnancy, or a new birth control question while you are using a GLP-1 medicine.
Frequently Asked Questions
How long do GLP-1 injection side effects last?
Digestive symptoms often appear when you start the medicine or raise the dose, and many people find they ease over the following weeks. This varies, and some people have symptoms that persist. If they do not improve or interfere with eating and drinking, tell your prescriber so they can decide whether to adjust the plan.
What can I eat to reduce nausea on Ozempic or Mounjaro?
Many people tolerate smaller, slower meals better, and find that greasy, fried or very sweet foods make nausea worse. Sipping fluids through the day may also help. These are general comfort measures, not treatment. If nausea is persistent or you cannot eat or drink enough, contact your clinician or pharmacist for advice.
Can GLP-1 injections cause low blood sugar?
On their own they carry a lower risk of low blood sugar. The risk rises when they are combined with insulin or sulfonylurea pills, or when you eat much less than usual. Ask your prescriber whether your other diabetes medicines need adjusting, and do not change them yourself. Severe symptoms such as fainting or seizure need 911.
What is the boxed warning on GLP-1 medicines?
The prescribing information for semaglutide, liraglutide, dulaglutide and tirzepatide products carries a boxed warning about thyroid C-cell tumors seen in rodents. It is not known whether they cause such tumors in people. They are not recommended with a personal or family history of medullary thyroid carcinoma or MEN 2. Tell your clinician about that history before starting.
Which stomach pain after a GLP-1 shot needs urgent care?
Mild cramping that comes and goes is common. Severe, persistent pain in the abdomen, especially if it spreads to the back or comes with repeated vomiting, can be a sign of pancreatitis and needs emergency care; tell the team you use a GLP-1 medicine and let them and your prescriber decide about holding it. Belly swelling with vomiting and no stool or gas can signal a blockage. Right-sided pain with fever or yellow skin or eyes can signal a gallbladder problem.
Do I need to tell my surgeon I use a GLP-1 medicine?
Yes. These medicines slow stomach emptying, which may raise the chance that food remains in the stomach during anesthesia or sedation. Tell the surgeon, the anesthesia team and the clinician doing any procedure, so they can decide what instructions to give you. Do not stop or change the medicine yourself without their guidance.
Can GLP-1 injections cause hair loss?
Some people report hair thinning while using them. The cause is not fully understood, and rapid weight loss, lower calorie and protein intake, and other factors may contribute. If you notice shedding, tell your clinician, who can check for other causes such as thyroid problems or low iron and review your nutrition.
Can I get pregnant while taking a GLP-1 medicine?
Wegovy and Zepbound are not recommended in pregnancy, and their labels advise stopping before a planned pregnancy (semaglutide labeling advises at least 2 months). Tell your prescriber if you are planning or become pregnant. Tirzepatide can also reduce oral contraceptive effectiveness, so labeling advises a backup or non-oral method for 4 weeks after starting and after each dose increase.
Related articles
Can You Take Ozempic If You Don't Have Diabetes?Metformin: Uses, Side Effects, and What to KnowSGLT2 Inhibitors: Why Do These Diabetes Pills Also Protect the Heart and Kidneys?Sources
- MedlinePlus (NIH) - Diabetes Medicines
- MedlinePlus (NIH) - Hypoglycemia
- MedlinePlus (NIH) - Diabetes Type 2
- MedlinePlus (NIH) - Diabetes